Doctors Generally Confident With Deprescribing for Elderly

Share this content:
Doctors Generally Confident With Deprescribing for Elderly
Doctors Generally Confident With Deprescribing for Elderly

TUESDAY, May 1, 2018 (HealthDay News) -- Physicians are generally comfortable with deprescribing for elderly patients, although there are several barriers to deprescribing, according to a study published online April 22 in the Journal of Clinical Pharmacy and Therapeutics.

Laurence Djatche, Pharm.D., from Thomas Jefferson University in Philadelphia, and colleagues administered a survey to 160 physicians attending an educational session related to deprescribing. Participants were asked to assess their level of agreement on nine questions relating to their perception of deprescribing and potential factors affecting the process of deprescribing.

The researchers found that 72 percent of physicians reported general confidence in their ability to deprescribe. Seventy-eight and 53 percent reported being comfortable deprescribing preventive and guideline-recommended therapy, respectively. More than one-third of physicians reported lack of evidence on discontinuing preventive medicines and concern about withdrawal side effects as impeding deprescribing. Forty percent of physicians reported hesitance in deprescribing medications when they were initially prescribed by another physician. Forty-five percent did not feel comfortable deprescribing when patients/caregivers believed that the medication was still needed. About one in four physicians reported lack of time and difficulty engaging patients/caregivers as barriers in the deprescribing process. No strong correlation was identified between physicians' confidence and attitudes or barriers associated with deprescribing.

"An improved understanding of physicians' views on deprescribing may help guide further research, and policies to help patients remain healthy while streamlining their medication regimen," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

8 More U.S. Communities to Be Assessed for PFAS Toxin Exposure

8 More U.S. Communities to Be Assessed for ...

Assessments will lay groundwork for future study of the health effects of perfluoroalkyl, polyfluoroalkyl

FDA Advances Regulation to Ensure Sunscreen Safety, Efficacy

FDA Advances Regulation to Ensure Sunscreen Safety, Efficacy

Proposed rule will help consumers better understand what the sunscreens they are buying can actually do

U.S. Agencies Probing Johnson  Johnson Over Asbestos in Talc

U.S. Agencies Probing Johnson & Johnson Over Asbestos ...

Company has faced lawsuits linking its body powders with ovarian cancer or mesothelioma

is free, fast, and customized just for you!




Already a member?

Sign In Now »